BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ARUP Laboratories Celebrates New State-of-the-art Diagnostic Technology with the Ventana Medical Systems, Inc. (VMSI) BenchMark Special Stains system


5/17/2012 11:01:02 AM

TUCSON, Ariz., May 17, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced the unveiling of its new state-of-the-art BenchMark Special Stains system during a ribbon-cutting ceremony at ARUP (Associated Regional and University Pathologists) Laboratories in Salt Lake City, Utah.

Built on its industry-leading VENTANA BenchMark technology, the new BenchMark Special Stains system offers baking through staining automation; random batch access; connectivity to the VANTAGE workflow solution and connectivity to the VENTANA CareGiver (1) remote support system. These features enable full walk away automation, making it an ideal platform for laboratories worldwide.

"I'm looking forward to realizing the full potential of the Ventana BenchMark Special Stainer in our Histology Laboratory. It fully automates the deparaffinization step of our histology procedure, enabling the reassignment of our lab personnel to more value-added tasks," said Ken Metzger, histology supervisor at ARUP Laboratories.

"As a market leader and innovator in anatomic pathology, Ventana is committed to improving the lives of all patients afflicted with cancer," says Adrian Ralph, Ventana Lifecycle Leader, Primary Staining. "By building on our industry-leading VENTANA BenchMark platform technology, we bring to market a new special stains instrument that will empower our customers to deliver the highest standards of patient care through the most innovative diagnostic solutions available globally."

Ventana is the industry leader (2) in the special stains instrument market. With this latest addition to the BenchMark family of instruments, Ventana is introducing a special stains system that dramatically enhances testing efficiency over manual processes, enabling laboratories to consistently deliver exceptional quality, consistency, reliability, and workflow efficiency. And, as part of maintaining VENTANA world class standards, the platform and reagent kits are designed to maximize both the efficiency as well as the safety of lab personnel.

WATCH this revealing demonstration of manual staining workflow vs. the new BenchMark Special Stains instrument.

(1) VENTANA CareGiver remote support delivers a comprehensive histology remote connectivity solution for VENTANA systems including the BenchMark Special Stains platform, SYMPHONY H&E stainer and BenchMark ULTRA IHC/ISH stainer.

(2) Ventana internal sales and market assessments, 2011

About Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. ("VMSI") (SIX: RO, ROG; OTCQX: RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company's intuitive, integrated staining, workflow management platforms, and digital pathology solutions optimize laboratory efficiencies to reduce errors, support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, VMSI is driving Personalized Healthcare through accelerated drug discovery and the development of "companion diagnostics" to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.
VENTANA, the VENTANA logo, SYMPHONY and BenchMark are trademarks of Roche.

SOURCE Ventana Medical Systems, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES